pragma.vision Your technology observatory

Verification register Bio, Health & Neuro

Readiness verdict

Roche Sequencing by Expansion (SBX)

A dated reading of what is claimed, reported, and independently verified in the current evidence.

As of
2026-06-28
Revision
1
Method
v1.0.0

Current reading

The readiness gap, in one scan

AI-assisted assembly · derived results

Claimed
55

Public ambition and stated capability

Reported
52

Observed practitioner reporting

Verified
47

Independently supported evidence

Gap
+8

Claimed minus verified

Evidence strength Strong

Decision

What the current evidence supports

Human editorial judgment · 2026-06-28

Track closely; pilot-scope on launch

Why
The two biggest prior unknowns are now resolved: pricing is public ($150/genome, $750k box, ~half a NovaSeq X) and a launch date exists (summer 2026). Speed/accuracy signals are strong (sub-4h sample-to-VCF, NovaSeq-comparable calling) but it is still RUO pre-GA with a basecaller quirk needing ecosystem adaptation, so it is track-and-prepare, not adopt-now.
Next
Watch the summer-2026 Axelios 1 GA and the first independent (non-Roche) WGS benchmark on shipped instruments; confirm the $150/genome figure holds with real consumable pricing (it assumes 20x microwell reuse) before pilot scoping.

Constraints

Blockers

No named blocker is present in the current public projection.

Evidence summary

Derived counts

AI-assisted assembly

Total
7
Tier 1
2
Tier 2
1
Tier 3
4
Supports
3
Contradicts
2
Context
2
Latest observed
2026-02-01

Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.

Publication record

Revisions

Initial public reading

This is the initial public reading. No earlier readiness change is recorded.

Your opinion

Tell us anything.

What works, what doesn't, what's missing — especially about our watches, lenses, and the register itself. Anonymous is fine; leave an email if you'd like a reply.